Compression the efficacy of Topiramate and Propranolol in patients with migraine
Phase 2
Recruiting
- Conditions
- Migraine.Migraine
- Registration Number
- IRCT20201031049208N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 32
Inclusion Criteria
Age group 18 to 65 years
History of migraine with Aura (according to the definition of the international classification of headache disorders)
Patients with the frequency of migraine attacks at least once a week
Exclusion Criteria
Systolic blood pressure below 90 mmHg
Heart rate below 65 beats per minute
Incidence of tension-type headache attacks in the last month
Previous history of analgesia or migraine specific medication
History of known allergy to Topiramate or Propranolol
History of kidney stone
History of depression
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessing the degree of disability. Timepoint: Before and after 3 months of taking the drug. Method of measurement: Migraine Disability Assessment (MIDAS) scale questionnaire.
- Secondary Outcome Measures
Name Time Method